Search
for
Sort by
Research 30 of 72
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs
- Body image and mental health in women with polycystic ovary syndrome–a cross-sectional study
- Debatable Topics in PCOS Patients
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Health-related quality of life and mental state in women with polycystic ovary syndrome and migration or minority background – A cross-sectional study
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Translating Resveratrol Research: A Systematic Review on Patents and Clinical Trials (2000–2025)
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Maternal obesity and the metabolic syndrome in reproductive health: assessing incretin-based interventions
- HAIR-AN Syndrome: A Systematic Review of Clinical, Metabolic, and Hormonal Features in Women of Reproductive Age
- Hair loss during treatment of obesity: current state of the problem and potential solutions
- Nutritive diet becomes unhealthy if taken in a wrong ratio: Scientific validation of Ayurvedic concept of “incompatible diet” (<i>Virrudh Aahar</i>)
- Polycystic ovary syndrome and infertility: an update
- Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment—A Single Center Case Series
- Poster Abstracts
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- <i>Acorus calamus</i>: a bio-reserve of medicinal values
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- A review on PCOS: Its causes, symptoms, pathogenesis and management
- Can gut flora changes be new biomarkers for depression?
- A 6-Month Prospective, Open-Label, Randomized Study Showing Increased Hair Growth Rate in Women Using Multi-Targeting Hair Growth Nutraceuticals
- From Anti-Aging Medicine to Precision Healthspan Pharmacology: Evidence Domains, Monitoring Requirements, and Practical Boundaries
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- The Impact of Bariatric Surgery on the Development and Progression of Dermatologic Diseases: A Narrative Review